The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia

@article{Mortensen2005TheIO,
  title={The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia},
  author={Eric M Mortensen and Marcos I Restrepo and Antonio Anzueto and Jacqueline A. Pugh},
  journal={Critical Care},
  year={2005},
  volume={10},
  pages={R8 - R8}
}
INTRODUCTION National clinical practice guidelines have recommended specific empiric antimicrobial regimes for patients with severe community-acquired pneumonia. However, evidence confirming improved mortality with many of these regimes is lacking. Our aim was to determine the association between the empiric use of a β-lactam with fluoroquinolone, compared with other recommended antimicrobial therapies, and mortality in patients hospitalized with severe community-acquired pneumonia. METHODS A… CONTINUE READING